Concepedia

Ingrid Fátima Zattoni

IF

5

Publications

105

Citations

5

H-Index

2016

Active since

Affiliations

Universidade Federal do Paraná(Current)

National Institutes of Health

National Cancer Institute

Center for Cancer Research

University of Eastern Finland

Ingrid Fátima Zattoni is an author at Universidade Federal do Paraná specializing in drug discovery, drug resistance, and medicine.

ORCID

Top concepts

Publications per year

2016–2021

5

Publications

5

Photodynamic effect of meso-(aryl)porphyrins and meso-(1-methyl-4-pyridinium)porphyrins on HaCaT keratinocytes

Amanda Martinez Slomp, Sandra Mara Woranovicz Barreira, Luise Zozula Blind Carrenho et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 32 citations

, , +4

Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles

Diogo Henrique Kita, Nathalie Guragossian, Ingrid Fátima Zattoni et al. · Scientific Reports · 2021 · 30 citations · Full text

Tetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)

Luis C. Vesga, Thales Kronenberger, Arun Kumar Tonduru et al. · ChemMedChem · 2021 · 18 citations · Full text

, , +15

A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP/ABCG2)

Ingrid Fátima Zattoni, Thales Kronenberger, Diogo Henrique Kita et al. · Chemico-Biological Interactions · 2021 · 15 citations · Full text

, , +9

Polyoxovanadates as new P‐glycoprotein inhibitors: insights into the mechanism of inhibition

Diogo Henrique Kita, Gisele Alves de Andrade, Juliana Morais Missina et al. · FEBS Letters · 2021 · 10 citations · Full text

Rows per page

1–5 of 5